Contact: Li Tel :027-87738627 QQ: 2387256661 Chinese name: olmesartan medoxomil olmesartan medoxomil (Olmesartan Medoxomi I) Japan S ankyo (Sankyo) and U.S. Fo rest La boratories developed by May 2002 in order to trade name Benicar in the United States, was approved in August 2000 and listed in Germany in early October. Olmesartan effective than losartan losartan and other drugs listed earlier, as an ideal anti-high blood pressure medications I, for various types of high pressure have a better effect, it features a longer half-life can be effective control of blood pressure during the day, so taking more convenient. Concurrently with other angiotensin II receptor antagonists compared. With a small dose, rapid onset of the antihypertensive effect of a stronger and lasting, significant advantages of low rate of adverse reactions. Clinical studies have shown that: olmesartan also be used with other antihypertensive drugs while taking in order to achieve better therapeutic effect. In addition, olmesartan atherosclerosis, cardiac hypertrophy, heart failure, diabetes, kidney etc with good effect. Olmesartan medoxomil [1] Product Category: Pharmaceutical raw materials and intermediates Appearance: light yellow to white powder Solubility in water insoluble; slightly soluble in methanol; soluble in glacial acetic acid Melting point: 175.0 -180.0 ℃ Relative Density: 1.37g / cm3 [2] Product content:> 99% Chemical formula: C29H30N6O6 CAS No.: 144689-63-4 [2] Quality Standard: MW: 560.61